BEAM
Price
$26.10
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
116 days until earnings call
SANA
Price
$3.10
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
125 days until earnings call
Ad is loading...

BEAM vs SANA

Header iconBEAM vs SANA Comparison
Open Charts BEAM vs SANABanner chart's image
Beam Therapeutics
Price$26.10
Change-$0.00 (-0.00%)
Volume$934.89K
CapitalizationN/A
Sana Biotechnology
Price$3.10
Change-$0.00 (-0.00%)
Volume$2.72M
CapitalizationN/A
View a ticker or compare two or three
BEAM vs SANA Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BEAM vs. SANA commentary
Nov 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and SANA is a StrongSell.

COMPARISON
Comparison
Nov 09, 2024
Stock price -- (BEAM: $26.09 vs. SANA: $3.10)
Brand notoriety: BEAM and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 87% vs. SANA: 200%
Market capitalization -- BEAM: $2.24B vs. SANA: $689.64M
BEAM [@Biotechnology] is valued at $2.24B. SANA’s [@Biotechnology] market capitalization is $689.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $467.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileSANA’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • SANA’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than SANA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 4 bearish.
  • SANA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BEAM and SANA are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а +19.08% price change this week, while SANA (@Biotechnology) price change was -11.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.66%. For the same industry, the average monthly price growth was +14.64%, and the average quarterly price growth was +11.72%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

SANA is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (+3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.24B) has a higher market cap than SANA($669M). BEAM YTD gains are higher at: -4.148 vs. SANA (-24.020). BEAM has higher annual earnings (EBITDA): -162.88M vs. SANA (-229.49M). BEAM has more cash in the bank: 1.01B vs. SANA (252M). SANA has less debt than BEAM: SANA (98.6M) vs BEAM (165M). BEAM has higher revenues than SANA: BEAM (353M) vs SANA (0).
BEAMSANABEAM / SANA
Capitalization2.24B669M335%
EBITDA-162.88M-229.49M71%
Gain YTD-4.148-24.02017%
P/E RatioN/AN/A-
Revenue353M0-
Total Cash1.01B252M400%
Total Debt165M98.6M167%
TECHNICAL ANALYSIS
Technical Analysis
BEAMSANA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 17 days ago
85%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIESX25.340.33
+1.32%
Calvert International Equity R6
JENIX66.680.78
+1.18%
Jensen Quality Growth I
JERAX12.110.10
+0.83%
Janus Henderson Global Real Estate A
FARMX18.27N/A
N/A
Fidelity Agricultural Productivity
VGRIX83.08-0.43
-0.51%
JPMorgan US Value A

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-1.99%
CRSP - BEAM
74%
Closely correlated
+2.29%
NTLA - BEAM
68%
Closely correlated
-0.37%
DNLI - BEAM
64%
Loosely correlated
+0.17%
EDIT - BEAM
64%
Loosely correlated
-3.35%
RXRX - BEAM
63%
Loosely correlated
-0.57%
More

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
-9.09%
BEAM - SANA
46%
Loosely correlated
-1.99%
CRSP - SANA
45%
Loosely correlated
+2.29%
RXRX - SANA
44%
Loosely correlated
-0.57%
AXON - SANA
43%
Loosely correlated
+2.01%
EDIT - SANA
41%
Loosely correlated
-3.35%
More